These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 34528556

  • 1. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
    Kumari P, Sharma I, Saha SC, Srinivasan R, Minhas P.
    J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
    [Abstract] [Full Text] [Related]

  • 2. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer.
    Kumari P, Sharma I, Saha SC, Srinivasan R, Bhardwaj P.
    Indian J Med Res; 2022 Sep; 156(3):516-523. PubMed ID: 36751747
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
    Tian X, Xu L, Wang P.
    Int J Clin Exp Pathol; 2015 Sep; 8(5):4933-42. PubMed ID: 26191186
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X.
    Clin Cancer Res; 2013 Mar 01; 19(5):1213-24. PubMed ID: 23362326
    [Abstract] [Full Text] [Related]

  • 11. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M, Danielska J, Domanska-Senderowska D, Dzieniecka M, Szymanska B, Malinowski A.
    Acta Obstet Gynecol Scand; 2018 May 01; 97(5):560-569. PubMed ID: 29355888
    [Abstract] [Full Text] [Related]

  • 12. Promoter methylation status of key genes and its implications in the pathogenesis of endometriosis, endometrioid carcinoma of ovary and endometrioid endometrial cancer.
    Kumari P, Sharma I, Saha SC, Srinivasan R, Sharma A.
    J Cancer Res Ther; 2022 Dec 01; 18(Supplement):S328-S334. PubMed ID: 36510984
    [Abstract] [Full Text] [Related]

  • 13. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N, Kai K, Tsuno A, Nasu K, Kashima K, Narahara H.
    Arch Gynecol Obstet; 2011 Oct 01; 284(4):951-5. PubMed ID: 21046134
    [Abstract] [Full Text] [Related]

  • 14. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS, Andersen JD, Harrington KM, Pambuccian SE, Kalloger SE, Boylan KL, Argenta PA, Skubitz AP.
    Am J Clin Pathol; 2009 Dec 01; 132(6):846-56. PubMed ID: 19926575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S, Leslie KK.
    Oncol Rep; 2011 Oct 01; 26(4):995-1002. PubMed ID: 21725615
    [Abstract] [Full Text] [Related]

  • 17. Identification of MicroRNAs as Potential Biomarkers in Ovarian Endometriosis.
    Gu CL, Zhang Z, Fan WS, Li LA, Ye MX, Zhang Q, Zhang NN, Li Z, Meng YG.
    Reprod Sci; 2020 Sep 01; 27(9):1715-1723. PubMed ID: 32651898
    [Abstract] [Full Text] [Related]

  • 18. Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.
    Záveský L, Jandáková E, Weinberger V, Minář L, Hanzíková V, Dušková D, Drábková LZ, Svobodová I, Hořínek A.
    Reprod Sci; 2019 Apr 01; 26(4):510-522. PubMed ID: 29779470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.